GENEWELL™ tests for genetic variants involved in physiological processes that are linked to an increased risk for certain lifestyle-related, chronic diseases, including:
- Blood clotting
- Bone Health
- Caffeine Metabolism
- Cancer risk
- Cholesterol and lipid metabolism
- Circadian rhythms (sleep disorders)
- Dietary carbohydrate sensitivity
- Dietary fat sensitivity
- Drug metabolism
- Exercise responsiveness
- Heart disease
- Homocysteine metabolism
- Insulin sensitivity and risk for diabetes
- Iron metabolism
- Lactose Intolerance
- Oxidative Stress
- Vitamin-B metabolism
- Salt Sensitivity
- Stress and Mood Disorders (eg Depression / Anxiety)
GENE-Rx™ will provide insight into how a patient metabolises, transports and binds certain prescription drugs, which empowers physicians to prescribe medication that will most likely be the most effective for first-time treatment. Physicians will, therefore, be able to identify individuals at risk of experiencing treatment failure and adverse side effects from treatment based on their genetic makeup.
The ultimate goal is personalised medicine identifying genetic biomarkers affecting drug response, to better guide drug therapy decisions for an individual. This will significantly improve the treatment of disease.
Currently, most doctors base their drug prescription on symptoms and factors such as the patient’s age, weight, sex and organ functionality. However, for a large subset of drugs, genetic variations have been identified and research is available that indicates how a person with these genetic variations, is likely to respond to these drugs.